Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ⅲ Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Arterial Hypertension Patients

NCT01712997 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT01712997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01712997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ⅲ Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Arterial Hypertension Patients
Lead sponsor
Air Force Military Medical University, China
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2012
Completion date
Not reported
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension